Astrocytes Protect against Isoflurane Neurotoxicity by Buffering pro-brain–derived Neurotrophic Factor

Abstract

Background Isoflurane induces cell death in neurons undergoing synaptogenesis via increased production of pro-brain derived neurotrophic factor (proBDNF) and activation of post-synaptic p75 neurotrophin receptor (p75NTR). Astrocytes express p75NTR but their role in neuronal p75NTR mediated cell death remains unclear. We investigated whether astrocytes have the capacity to buffer increases in proBDNF and protect against isoflurane/p75NTR neurotoxicity. Methods Cell death was assessed in day-in-vitro (DIV) 7 mouse primary neuronal cultures alone or in co-culture with age-matched or DIV 21 astrocytes with propidium iodide 24 hours following 1 hour exposure to 2% isoflurane or recombinant proBDNF. Astrocyte-targeted knockdown of p75NTR in co-culture was achieved with small interfering RNA and astrocyte-specific transfection reagent and verified with immunofluorescence microscopy. proBDNF levels were assessed by enzyme-linked immunosorbent assay. Each experiment used 6–8 replicate cultures/condition, and was repeated at least three times. Results Exposure to isoflurane significantly (p<0.05) increased neuronal cell death in primary neuronal cultures (1.5±0.7 fold, mean±SD) but not in co-culture with DIV 7 (1.0±0.5 fold) or DIV 21 astrocytes (1.2±1.2 fold). Exogenous proBDNF dose dependently induced neuronal cell death in both primary neuronal and co-cultures, an effect enhanced by astrocyte p75NTR inhibition. Astrocyte-targeted p75NTR knockdown in co-cultures increased media proBDNF (1.2±0.1 fold) and augmented isoflurane induced neuronal cell death (3.8±3.1 fold). Conclusions The presence of astrocytes provides protection to growing neurons by buffering elevated levels of proBDNF induced by isoflurane. These findings may hold clinical significance for the neonatal and injured brain where elevated levels of proBDNF impair neurogenesis.

Conditional BDNF delivery from astrocytes rescues memory deficits, spine density and synaptic properties in the 5xFAD mouse model of Alzheimer disease

“…Second, facilitating BDNF expression from astrocytes has previously been shown to be useful in another neurodegenerative disease, Huntington's disease (Giralt et al, 2011;Corbett et al, 2013;Reick et al, 2016). Furthermore, astrocytes per se not only produce, but also buffer, BDNF in case of necessity (Stary et al, 2015) or recycle it for LTP maintenance and memory retention (Vignoli et al, 2016), thus making them perfect candidates to deliver the neurotrophin in a controlled fashion. Additionally, in the field of cell therapy, astrocytes would be good therapeutic tools because they survive for a long time when grafted (Giralt et al, 2010), and they are specifically reactive where A␤ is accumulated and where neuritic dystrophy is localized (Song et al, 2015).…”

Resolving the contributions of anaesthesia, surgery, and nerve injury on brain derived neurotrophic factor expression in the medial prefrontal cortex of male rats in the CCI model of neuropathic pain

“…Erasso et al () showed that inhalation of isoflurane for 3 hours resulted in an increase in the number of astrocytes present in the dentate gyrus of the hippocampus. An increased number of astrocytes present in the mPFC may provide a neuroprotective mechanism as the re‐uptake of pro‐BDNF by astrocytes has previously been shown to protect against isoflurane neurotoxicity (Stary, Sun, & Giffard, ). Increasing literature on the role of neurotrophic signalling in the developing brain suggests general anaesthetic induced BDNF expression are linked to the activation of apoptotic signalling (Lu, Yon, Carter, & Jevtovic‐Todorovic, ; Lemkuil et al, ).…”

miR-29a differentially regulates cell survival in astrocytes from cornu ammonis 1 and dentate gyrus by targeting VDAC1

“…#MC10518 and #4464076 respectively, ThermoFisher Scientific, Waltham, MA) using Lipofectamine-2000™ reagent (Invitrogen, Foster City, CA) according to the manufacturer’s instructions (Stary et al , 2015a). Relatively younger cultures were used in the present study to achieve a higher efficiency of transfection.…”